Annovis Bio announces trial design of the... - Cure Parkinson's

Cure Parkinson's

25,951 members27,242 posts

Annovis Bio announces trial design of their planned Phase 3 trial evaluating buntanetap (posiphen) in early Parkinsons

3 Replies

Annovis Bio announces trial design of their planned Phase 3 trial evaluating buntanetap (posiphen) in early #Parkinsons; 450 PD participants H&Y 1-3, randomized 1:1:1 (placebo, 10mg or 20mg once daily); MDS-UPDRS II & III as primary endpoints

twitter.com/ScienceofPD/sta...

irpages2.eqs.com/websites/a...

3 Replies
WinnieThePoo profile image
WinnieThePoo

Another good one

jrg54321 profile image
jrg54321

No locations posted here yet. clinicaltrials.gov/ct2/show...

related to

healthunlocked.com/cure-par...

You may also like...

ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE

endpoint=UPDRS II+III OFF https://twitter.com/ScienceofPD/status/1545320232666923009

Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease

the EU sites yet. https://www.prnewswire.com/news-releases/annovis-bio-announces-approval-for-europ

First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's

patient has been dosed in a clinical trial testing Annovis Bio’s buntanetap as an oral therapy for...

Update x2- Annovis to Announce Results for their Phase 3 trial of Buntanetap for Parkinson's end of June

Latest from Maria, as of Thursday June 20 https://youtu.be/X_vW360U094?si=ByDCCGUB6oLyswP- Latest...

Annovis Bio Buntanetap

With the Buntanetap phase III trial dosing ending soon, I noticed that Annovis Bio stock is dropping